Duo Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Duo Liu has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Hanjie Wang
Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China
9 shared publications Zhijie Feng
Hainan University
8 shared publicationsHongxiang Li
Tianjin University
7 shared publicationsMingshan Li
Tianjin University
7 shared publications- Ying-Jin Yuan
Tianjin University
7 shared publications Dawei Sun
Tianjin University
6 shared publications
Latest Publications
- 14 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (33) , 45037-45053
Ingestible Hydrogel-Encapsulated Optogenetic Yeast Controlled by Wearable Electronics Enables Programmable IL-10 Delivery for Inflammatory Bowel Disease Therapy
Engineered yeast-living drugs offer significant potential for oral protein therapy but remain limited by poor intestinal retention and lack of precise spatiotemporal control over therapeutic delivery. Here, we developed an ingestible hydrogel-encapsulated optogenetic yeast system controlled by a wearable electronic device for programmable interleukin-10 (IL-10) delivery in inflammatory bowel disease (IBD). We engineered Pichia pastoris with an EL222-based blue-light-inducible circuit achieving rapid, stringent IL-10 secretion (50% saturated concentration within just 1 h upon induction). The yeast was encapsulated in a photo-crosslinkable HAMA hydrogel that was gelated within 60 s upon blue-light exposure, exhibiting robust mechanical stability and tissue adhesion. A lightweight (2.27 g) wearable Bluetooth-controlled electronic device delivered targeted blue light transdermally, enabling simultaneous in situ hydrogel crosslinking and optogenetic activation in yeast cells. This system significantly extended the time yeast stays in the mouse gut, with reporter gene expression lasting over 5 h, while the unencapsulated control group lasted less than 2 h. In DSS-induced colitis mice, our strategy reduced proinflammatory cytokines (IL-1β, IL-6, and TNF-α) by >60%, restored intestinal barrier integrity, and normalized gut microbiota diversity to near-healthy levels, which performed significantly better than in other groups. This integrated “extracorporeal instruction−intracorporeal response” paradigm establishes a digitally programmable platform for precision live biotherapeutics. However, limited blue-light tissue penetration remains a key constraint; future work should focus on near-infrared photosensitive systems, programmable-degradation hydrogels, and wireless closed‑loop feedback to advance clinical translation.
- 14 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (33) , 45037-45053
Ingestible Hydrogel-Encapsulated Optogenetic Yeast Controlled by Wearable Electronics Enables Programmable IL-10 Delivery for Inflammatory Bowel Disease Therapy
Engineered yeast-living drugs offer significant potential for oral protein therapy but remain limited by poor intestinal retention and lack of precise spatiotemporal control over therapeutic delivery. Here, we developed an ingestible hydrogel-encapsulated optogenetic yeast system controlled by a wearable electronic device for programmable interleukin-10 (IL-10) delivery in inflammatory bowel disease (IBD). We engineered Pichia pastoris with an EL222-based blue-light-inducible circuit achieving rapid, stringent IL-10 secretion (50% saturated concentration within just 1 h upon induction). The yeast was encapsulated in a photo-crosslinkable HAMA hydrogel that was gelated within 60 s upon blue-light exposure, exhibiting robust mechanical stability and tissue adhesion. A lightweight (2.27 g) wearable Bluetooth-controlled electronic device delivered targeted blue light transdermally, enabling simultaneous in situ hydrogel crosslinking and optogenetic activation in yeast cells. This system significantly extended the time yeast stays in the mouse gut, with reporter gene expression lasting over 5 h, while the unencapsulated control group lasted less than 2 h. In DSS-induced colitis mice, our strategy reduced proinflammatory cytokines (IL-1β, IL-6, and TNF-α) by >60%, restored intestinal barrier integrity, and normalized gut microbiota diversity to near-healthy levels, which performed significantly better than in other groups. This integrated “extracorporeal instruction−intracorporeal response” paradigm establishes a digitally programmable platform for precision live biotherapeutics. However, limited blue-light tissue penetration remains a key constraint; future work should focus on near-infrared photosensitive systems, programmable-degradation hydrogels, and wireless closed‑loop feedback to advance clinical translation.
- Open Access
- 13 February 2026
- Published by Springer Nature in Research Square
Programming Microbe-Computer Interaction for Customized Life-Nonlife and Cross-Life Communication
The extension of human-computer interaction (HCI) paradigm to non-intelligent microbe-computer interaction (MCI) is attractive for building generalized life-nonlife communication. Main challenges lie in how to construct biohybrid interface within individual MCI unit and program communication among different units. Here, we designed opto-interfaced MCI unit composed of engineered microbes and computer terminals, for enabling quantifiable transduction between microbial signals and digital signals. These units were able to serve as life-centric biohybrid sensors, actuators and transceivers. Based on these units, we established programmable cross-life communication architectures capable of unicast, multicast, and logic-gate-driven communication with dynamic control. The architectures were validated in in multiple scenarios, including the biomedical monitoring-triggered therapeutic intervention at tumor, epidermal and intestinal scenarios, and the environmental unmanned monitoring of water contaminants. In summary, we provide a scalable strategy for building customized life-nonlife and cross-life communication, which is expected to complement living biosystems into the internet of things (IoT).
- 13 February 2026
- Published by Springer Nature in Research Square
Open AccessProgramming Microbe-Computer Interaction for Customized Life-Nonlife and Cross-Life Communication
The extension of human-computer interaction (HCI) paradigm to non-intelligent microbe-computer interaction (MCI) is attractive for building generalized life-nonlife communication. Main challenges lie in how to construct biohybrid interface within individual MCI unit and program communication among different units. Here, we designed opto-interfaced MCI unit composed of engineered microbes and computer terminals, for enabling quantifiable transduction between microbial signals and digital signals. These units were able to serve as life-centric biohybrid sensors, actuators and transceivers. Based on these units, we established programmable cross-life communication architectures capable of unicast, multicast, and logic-gate-driven communication with dynamic control. The architectures were validated in in multiple scenarios, including the biomedical monitoring-triggered therapeutic intervention at tumor, epidermal and intestinal scenarios, and the environmental unmanned monitoring of water contaminants. In summary, we provide a scalable strategy for building customized life-nonlife and cross-life communication, which is expected to complement living biosystems into the internet of things (IoT).
- Open Access
Programming Microbe-Computer Interaction for Customized Life-Nonlife and Cross-Life Communication
This extension of human-computer interaction (HCI) paradigm to the non-intelligent microbe-computer interaction (MCI) is attractive for building generalized life-nonlife communication. Main challenges lie in how to construct biohybrid interface within individual MCI unit and thereafter program cross-life communication based on these MCI units. Here, we propose the design and construction of opto-interfaced MCI unit composed of engineered microbes and computer terminals, for enabling quantifiable transduction between microbial signals and digital signals. These units were able to serve as biohybrid sensors, actuators and transceivers, supporting biomonitoring, bio-actuation and microbe-centric bidirectional operations. Based on these functional units, we established programmable cross-life communication architectures capable of unicast, multicast, and logic-gate-driven communication with temporal dynamic control. The architectures were validated in biomedical scenarios including tumor hypoxia biomarking, epidermal heavy metal detoxification, and colitis intervention, demonstrating robust performance in closed-loop diagnostic-therapeutic applications. Additionally, we integrated MCI with an unmanned surface vessel for environmental monitoring, highlighting its cross-domain potential. Collectively, we provide a scalable strategy for building customized life-nonlife and cross-life communication, which is expected as an important complement to internet of things (IoT).
Open AccessProgramming Microbe-Computer Interaction for Customized Life-Nonlife and Cross-Life Communication
This extension of human-computer interaction (HCI) paradigm to the non-intelligent microbe-computer interaction (MCI) is attractive for building generalized life-nonlife communication. Main challenges lie in how to construct biohybrid interface within individual MCI unit and thereafter program cross-life communication based on these MCI units. Here, we propose the design and construction of opto-interfaced MCI unit composed of engineered microbes and computer terminals, for enabling quantifiable transduction between microbial signals and digital signals. These units were able to serve as biohybrid sensors, actuators and transceivers, supporting biomonitoring, bio-actuation and microbe-centric bidirectional operations. Based on these functional units, we established programmable cross-life communication architectures capable of unicast, multicast, and logic-gate-driven communication with temporal dynamic control. The architectures were validated in biomedical scenarios including tumor hypoxia biomarking, epidermal heavy metal detoxification, and colitis intervention, demonstrating robust performance in closed-loop diagnostic-therapeutic applications. Additionally, we integrated MCI with an unmanned surface vessel for environmental monitoring, highlighting its cross-domain potential. Collectively, we provide a scalable strategy for building customized life-nonlife and cross-life communication, which is expected as an important complement to internet of things (IoT).
- Open Access
- 31 July 2025
- Published by Springer Nature in Microbial Cell Factories
- Vol. 24 (1) , 1-15
Coordinated synthesis of aromatic amino acid derived pigments in yeast via global transcriptional engineering
Rational metabolic pathway engineering is capable of boosting upstream flux towards downstream synthesis of target products, such as aromatic amino acid derivatives. However, coordinated synthesis of multiple downstream derivatives faces difficulty of combinatorial optimization of cellular metabolism. We developed a strategy combining metabolic engineering optimization with the global transcriptional regulation of transcription factors (TFs) Spt15p and Gcn4p to optimize the synthesis of aromatic amino acid derivatives in yeast. It is verified that the special mutants of these TFs can respectively improve the biosynthesis of betaxanthin, a tyrosine derived edible pigment. Comparative transcriptome analysis shows that significant transcriptional tuning occurs in glycolysis, pentose phosphate pathway, aromatic amino acid synthesis pathways, etc. In addition, global transcriptional engineering is proved to enhance the coordinated biosynthesis of both tyrosine derived pigment betaxanthin and tryptophan derived pigment violacein by more than 50%. Finally, we obtain an optimized production of 208 mg/L betaxanthin in yeast cells by flask fermentation. Our strategy supplies an effective way to optimize the coordinated synthesis of two structurally divergent pigments downstream of the common aromatic amino acid pathway.
- 31 July 2025
- Published by Springer Nature in Microbial Cell Factories
- Vol. 24 (1) , 1-15
Open AccessCoordinated synthesis of aromatic amino acid derived pigments in yeast via global transcriptional engineering
Rational metabolic pathway engineering is capable of boosting upstream flux towards downstream synthesis of target products, such as aromatic amino acid derivatives. However, coordinated synthesis of multiple downstream derivatives faces difficulty of combinatorial optimization of cellular metabolism. We developed a strategy combining metabolic engineering optimization with the global transcriptional regulation of transcription factors (TFs) Spt15p and Gcn4p to optimize the synthesis of aromatic amino acid derivatives in yeast. It is verified that the special mutants of these TFs can respectively improve the biosynthesis of betaxanthin, a tyrosine derived edible pigment. Comparative transcriptome analysis shows that significant transcriptional tuning occurs in glycolysis, pentose phosphate pathway, aromatic amino acid synthesis pathways, etc. In addition, global transcriptional engineering is proved to enhance the coordinated biosynthesis of both tyrosine derived pigment betaxanthin and tryptophan derived pigment violacein by more than 50%. Finally, we obtain an optimized production of 208 mg/L betaxanthin in yeast cells by flask fermentation. Our strategy supplies an effective way to optimize the coordinated synthesis of two structurally divergent pigments downstream of the common aromatic amino acid pathway.
- Top Cited Papers
- 28 July 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (8) , 1841-1853
Ingestible optoelectronic capsules enable bidirectional communication with engineered microbes for controllable therapeutic interventions
Engineered microbes can be used for biomolecular sensing and therapeutic interventions. However, they cannot be monitored and controlled while in vivo. Here we combine optogenetically engineered Escherichia coli Nissle 1917, an ingestible optoelectronic capsule and a wireless smartphone to establish a bidirectional biological–optical–electronic signal processing chain for diagnostic or therapeutic capabilities under user control. As a proof of concept, we engineered E. coli Nissle 1917 to detect inflammation-associated nitric oxide in the pig gut and generate a bioluminescent signal for diagnosis of colitis. This signal is transduced by the optoelectronic capsule into a wireless electrical signal and remotely monitored by a smartphone. Smartphone wireless signals activate LED irradiation in the optoelectronic capsule, in turn activating the microbial expression and secretion of an anti-inflammatory nanobody to alleviate colitis in pigs. This approach highlights the potential for integrating synthetic biology and optoelectronics for digital health monitoring and controllable intervention.
- 28 July 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (8) , 1841-1853
Top Cited PapersIngestible optoelectronic capsules enable bidirectional communication with engineered microbes for controllable therapeutic interventions
Engineered microbes can be used for biomolecular sensing and therapeutic interventions. However, they cannot be monitored and controlled while in vivo. Here we combine optogenetically engineered Escherichia coli Nissle 1917, an ingestible optoelectronic capsule and a wireless smartphone to establish a bidirectional biological–optical–electronic signal processing chain for diagnostic or therapeutic capabilities under user control. As a proof of concept, we engineered E. coli Nissle 1917 to detect inflammation-associated nitric oxide in the pig gut and generate a bioluminescent signal for diagnosis of colitis. This signal is transduced by the optoelectronic capsule into a wireless electrical signal and remotely monitored by a smartphone. Smartphone wireless signals activate LED irradiation in the optoelectronic capsule, in turn activating the microbial expression and secretion of an anti-inflammatory nanobody to alleviate colitis in pigs. This approach highlights the potential for integrating synthetic biology and optoelectronics for digital health monitoring and controllable intervention.
- 16 July 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 83, 108645
Advances in optogenetically engineered bacteria in disease diagnosis and therapy
- 16 July 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 83, 108645
Advances in optogenetically engineered bacteria in disease diagnosis and therapy
- Open Access
- 10 July 2025
- Published by Springer Nature in Nature Methods
- Vol. 22 (8) , 1686-1697
De novo assembly and delivery of synthetic megabase-scale human DNA into mouse early embryos
Epigenetic modifications on natural chromosomes are inherited and maintained in a default state, making it challenging to remove intrinsic marks to study the fundamental principles of their establishment and further influence on transcriptional regulation. In this study, we developed SynNICE, a method for assembling and delivering intact, naive, synthetic megabase (Mb)-scale human DNA into early mouse embryos, to study de novo epigenetic regulation. By assembling and delivering a 1.14-Mb human AZFa (hAZFa) locus, we observed the spontaneous incorporation of murine histones and the establishment of DNA methylation at the one-cell stage. Notably, DNA methylation from scratch strongly enriches at repeat sequences without H3K9me3 reinforcement. Furthermore, the transcription of hAZFa initiated at the four-cell stage is regulated by newly established DNA methylation. This method provides a unique platform for exploring de novo epigenomic regulation mechanisms in higher animals.
- 10 July 2025
- Published by Springer Nature in Nature Methods
- Vol. 22 (8) , 1686-1697
Open AccessDe novo assembly and delivery of synthetic megabase-scale human DNA into mouse early embryos
Epigenetic modifications on natural chromosomes are inherited and maintained in a default state, making it challenging to remove intrinsic marks to study the fundamental principles of their establishment and further influence on transcriptional regulation. In this study, we developed SynNICE, a method for assembling and delivering intact, naive, synthetic megabase (Mb)-scale human DNA into early mouse embryos, to study de novo epigenetic regulation. By assembling and delivering a 1.14-Mb human AZFa (hAZFa) locus, we observed the spontaneous incorporation of murine histones and the establishment of DNA methylation at the one-cell stage. Notably, DNA methylation from scratch strongly enriches at repeat sequences without H3K9me3 reinforcement. Furthermore, the transcription of hAZFa initiated at the four-cell stage is regulated by newly established DNA methylation. This method provides a unique platform for exploring de novo epigenomic regulation mechanisms in higher animals.
- Open Access
- 6 September 2024
- Published by Springer Nature in Research Square
A microbial-electronic optical communication language for intestinal monitoring and regulation
Gastrointestinal microbes play roles of biomolecular sensing and healthy intervention in human bodies but cannot be monitored and regulated by human instructions. Here, we establish a bidirectional optical communication language between engineered microbes and designer electronic capsules respectively based on photo sensing and optogenetics to realize remote monitoring and regulating of intestinal health. As a proof of concept, we engineer nitric oxide microbial biosensors to generate bioluminescent output signal for diagnosis of pig colitis, which is processed by electronic capsule and remotely monitored by smartphones. Reversely, smartphones send wireless signals to control LED luminescence in electronic capsule to activate the optogenetics of engineered microbes to relieve pig colitis. This language form of semiconductor synthetic biology enables new opportunities for health monitoring and active intervention.
- 6 September 2024
- Published by Springer Nature in Research Square
Open AccessA microbial-electronic optical communication language for intestinal monitoring and regulation
Gastrointestinal microbes play roles of biomolecular sensing and healthy intervention in human bodies but cannot be monitored and regulated by human instructions. Here, we establish a bidirectional optical communication language between engineered microbes and designer electronic capsules respectively based on photo sensing and optogenetics to realize remote monitoring and regulating of intestinal health. As a proof of concept, we engineer nitric oxide microbial biosensors to generate bioluminescent output signal for diagnosis of pig colitis, which is processed by electronic capsule and remotely monitored by smartphones. Reversely, smartphones send wireless signals to control LED luminescence in electronic capsule to activate the optogenetics of engineered microbes to relieve pig colitis. This language form of semiconductor synthetic biology enables new opportunities for health monitoring and active intervention.
- Open Access
Establishing remote communication between human operator and engineered intestinal microbe via bio-electronic optical language
Synthetic biology enables microbes to be engineered to detect biomarkers and deliver therapies in situ, offering advantages such as self-replication and localized response and treatment. However, the engineered microbes in the intestine remains a "black box", the status of microbial functionality is inaccessible, and the activation of microbial functions is uncontrollable. There is a demand of a "language" between microbes and human for real-time and in-situ monitoring and controlling engineered microbes in the intestine. Light, due to its advantages of specificity and accuracy in the body, was chosen as the language to establish an interactive communication path between human and the microbes with the features of sophisticated monitoring and controlling. For effectively remote operation of this "language" in the intestine, we introduced an electronic capsule as the intermedia, translating information and instructions understandable for human operator into bacterial regulatory and detectable signals in vivo. In this paper, the electronic capsule and the engineered Escherichia coli Nissle 1917 (EcN) strains were designed in a collaborative manner. An EcN-to-capsule bioluminescent signal transmission was established and testified as the language to report the status of engineered EcN, especially the response of EcN to intestinal environment. Similarly, another capsule-to-EcN optogenetic signal transmission was established and testified as the language to control the function of engineered EcN, especially the secretion of therapeutic substances. On this basis, bidirectional communication between human operator and intestinal microbes was achieved via bidirectional bio-electronic optical language. The communication was established to monitor and regulate engineered EcN community in the intestine in 50-90 kg live pigs. The in vitro and in vivo estimations demonstrated the capabilities of monitoring and regulating the engineered microbes, offering a remotely controllable language-based communication between human operator and internal intestinal microbes.
Open AccessEstablishing remote communication between human operator and engineered intestinal microbe via bio-electronic optical language
Synthetic biology enables microbes to be engineered to detect biomarkers and deliver therapies in situ, offering advantages such as self-replication and localized response and treatment. However, the engineered microbes in the intestine remains a "black box", the status of microbial functionality is inaccessible, and the activation of microbial functions is uncontrollable. There is a demand of a "language" between microbes and human for real-time and in-situ monitoring and controlling engineered microbes in the intestine. Light, due to its advantages of specificity and accuracy in the body, was chosen as the language to establish an interactive communication path between human and the microbes with the features of sophisticated monitoring and controlling. For effectively remote operation of this "language" in the intestine, we introduced an electronic capsule as the intermedia, translating information and instructions understandable for human operator into bacterial regulatory and detectable signals in vivo. In this paper, the electronic capsule and the engineered Escherichia coli Nissle 1917 (EcN) strains were designed in a collaborative manner. An EcN-to-capsule bioluminescent signal transmission was established and testified as the language to report the status of engineered EcN, especially the response of EcN to intestinal environment. Similarly, another capsule-to-EcN optogenetic signal transmission was established and testified as the language to control the function of engineered EcN, especially the secretion of therapeutic substances. On this basis, bidirectional communication between human operator and intestinal microbes was achieved via bidirectional bio-electronic optical language. The communication was established to monitor and regulate engineered EcN community in the intestine in 50-90 kg live pigs. The in vitro and in vivo estimations demonstrated the capabilities of monitoring and regulating the engineered microbes, offering a remotely controllable language-based communication between human operator and internal intestinal microbes.
- Open Access
Luminescent ingestible electronic capsules for in vivo regulation of optogenetic engineered bacteria
The ideal engineered microbial smart-drug should be capable of functioning on demand at specific sites in vivo. However, precise regulation of engineered microorganisms poses challenges in the convoluted and elongated intestines. Despite the promising application potential of optogenetic regulation strategies based on light signals, the poor tissue penetration of light signals limits their application in large experimental animals. Given the rapid development of ingestible electronic capsules in recent years, taking advantage of them as regulatory devices to deliver light signals in situ to engineered bacteria within the intestines has become feasible. In this study, we established an electronic-microorganism signaling system, realized by two Bluetooth-controlled luminescent electronic capsules were designed. The "Manager" capsule is equipped with a photosensor to monitor the distribution of engineered bacteria and to activate the optogenetic function of the bacteria by emitting green light. The other capsule, "Locator", can control the in situ photopolymerization of hydrogels in the intestines via ultraviolet light, aiding in the retention of engineered bacteria at specific sites. These two electronic capsules are expected to work synergistically to regulate the distribution and function of engineered bacteria in vivo, and their application in the treatment of colitis in pigs is currently being investigated, with relevant results to be updated subsequently.
Open AccessLuminescent ingestible electronic capsules for in vivo regulation of optogenetic engineered bacteria
The ideal engineered microbial smart-drug should be capable of functioning on demand at specific sites in vivo. However, precise regulation of engineered microorganisms poses challenges in the convoluted and elongated intestines. Despite the promising application potential of optogenetic regulation strategies based on light signals, the poor tissue penetration of light signals limits their application in large experimental animals. Given the rapid development of ingestible electronic capsules in recent years, taking advantage of them as regulatory devices to deliver light signals in situ to engineered bacteria within the intestines has become feasible. In this study, we established an electronic-microorganism signaling system, realized by two Bluetooth-controlled luminescent electronic capsules were designed. The "Manager" capsule is equipped with a photosensor to monitor the distribution of engineered bacteria and to activate the optogenetic function of the bacteria by emitting green light. The other capsule, "Locator", can control the in situ photopolymerization of hydrogels in the intestines via ultraviolet light, aiding in the retention of engineered bacteria at specific sites. These two electronic capsules are expected to work synergistically to regulate the distribution and function of engineered bacteria in vivo, and their application in the treatment of colitis in pigs is currently being investigated, with relevant results to be updated subsequently.